Baxter International Slides 6.5% After Deal to Sell Kidney Care Business to Carlyle Group

By MarketWatch | Aug 13, 2024 at 11:52 AM EST

Baxter International's shares fell after announcing the sale of its kidney-care business to Carlyle Group for $3.8 billion. The deal aims to reduce debt and facilitate strategic changes. The business, named Vantive, had $4.5 billion revenue last year.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.